Shanghai Kehua Bio-engineering Co Ltd (002022):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai Kehua Bio-engineering Co Ltd (002022) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0908
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai Kehua Bio-engineering Co Ltd (002022) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, chemiluminescence reagents; and laboratory instruments such as clinical chemistry analyzers, electrolyte analyzers, microplate readers, nucleic acid extractors and automatic chemiluminescence analyzers. It is one of the global suppliers of WHO, UNICEF, PEPFAR, and the Clinton HIV/AIDS Initiative. The company has sales supports facilities in major cities in China and it markets products in China and other countries through distributors. KHB is headquartered in Shanghai, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Shanghai Kehua Bio-engineering Co Ltd – Key Facts
Shanghai Kehua Bio-engineering Co Ltd – Key Employees
Shanghai Kehua Bio-engineering Co Ltd – Major Products and Services
Shanghai Kehua Bio-engineering Co Ltd – History
Shanghai Kehua Bio-engineering Co Ltd – Company Statement
Shanghai Kehua Bio-engineering Co Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Shanghai Kehua Bio-engineering Co Ltd – Business Description
Shanghai Kehua Bio-engineering Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Shanghai Kehua Bio-engineering Co Ltd – Strengths
Shanghai Kehua Bio-engineering Co Ltd – Weaknesses
Shanghai Kehua Bio-engineering Co Ltd – Opportunities
Shanghai Kehua Bio-engineering Co Ltd – Threats
Shanghai Kehua Bio-engineering Co Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Shanghai Kehua Bio-engineering Co Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Shanghai Kehua Bio-engineering Co Ltd, Key Facts
Shanghai Kehua Bio-engineering Co Ltd, Key Employees
Shanghai Kehua Bio-engineering Co Ltd, Major Products and Services
Shanghai Kehua Bio-engineering Co Ltd, History
Shanghai Kehua Bio-engineering Co Ltd, Subsidiaries
Shanghai Kehua Bio-engineering Co Ltd, Key Competitors
Shanghai Kehua Bio-engineering Co Ltd, Ratios based on current share price
Shanghai Kehua Bio-engineering Co Ltd, Annual Ratios
Shanghai Kehua Bio-engineering Co Ltd, Annual Ratios (Cont...1)
Shanghai Kehua Bio-engineering Co Ltd, Annual Ratios (Cont...2)
Shanghai Kehua Bio-engineering Co Ltd, Interim Ratios
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Type, 2014 to YTD 2020
Shanghai Kehua Bio-engineering Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Shanghai Kehua Bio-engineering Co Ltd, Performance Chart (2014 - 2018)
Shanghai Kehua Bio-engineering Co Ltd, Ratio Charts
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals By Year, 2014 to YTD 2020
Shanghai Kehua Bio-engineering Co Ltd, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Shanghai Kehua Bio-engineering Co Ltd (002022):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hutchison China Meditech Ltd
    Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report Summary Hutchison China Meditech Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Henry Lamotte Group:戦略・SWOT・企業財務分析
    Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report Summary Henry Lamotte Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Pentair plc (PNR)-エネルギー分野:企業M&A・提携分析
    Summary Pentair plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water system products and solutions for filtration, separation and fluid process management; and products that guard sensitive electrical and electronic equipment; and heat management solutions …
  • BlueCrest Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary BlueCrest Energy Inc (BlueCrest) is a privately held exploration and production company. The company primary focused on the extraction, acquisition, drilling, developing, and exploration of oil and gas resources within Alaska, the US. BlueCrest’ soil and gas assets are located approximately …
  • Crane Co:企業の戦略・SWOT・財務分析
    Crane Co - Strategy, SWOT and Corporate Finance Report Summary Crane Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Synairgen Plc (SNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Synairgen plc (Synairgen) is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). Its pipeline portfolio includes inhaled interferon beta (IFN-ß/SNG …
  • Reynard Corporation:企業の戦略・SWOT・財務情報
    Reynard Corporation - Strategy, SWOT and Corporate Finance Report Summary Reynard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • C&A:戦略・SWOT・企業財務分析
    C&A - Strategy, SWOT and Corporate Finance Report Summary C&A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • TOP Ships Inc (TOPS):石油・ガス:M&Aディール及び事業提携情報
    Summary TOP Ships Inc (Top Ships), formerly known as Top Tankers Inc., is a provider of international seaborne transportation services. It owns and operates eco medium range (MR) tanker vessels focusing on the transportation of petroleum products, crude oil and bulk liquid chemicals. The company ser …
  • GSI Technology, Inc. (GSIT):企業の財務・戦略的SWOT分析
    GSI Technology, Inc. (GSIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Mayo Foundation for Medical Education and Research:企業の戦略的SWOT分析
    Mayo Foundation for Medical Education and Research - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …
  • CDW Corporation:企業の戦略・SWOT・財務情報
    CDW Corporation - Strategy, SWOT and Corporate Finance Report Summary CDW Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kentucky Power Co:発電所・企業SWOT分析
    Kentucky Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • GeneNews Ltd (GEN):医療機器:M&Aディール及び事業提携情報
    Summary GeneNews Ltd (GeneNews) is a provider of molecular diagnostic products. The company develops and commercializes diagnostics and personalized medicine for cancer and other chronic diseases. Its Sentinel Principle is a novel approach to identifying biomarkers of body state using blood. GeneNew …
  • KornFerry International (KFY):企業の財務・戦略的SWOT分析
    KornFerry International (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includ …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Ace Hardware Corporation:企業の戦略的SWOT分析
    Ace Hardware Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Celularity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celularity Inc (Celularity) is a biotechnology company that develops and commercializes therapeutics derived from the placenta for autoimmune and degenerative diseases, immuno-oncology, and functional regeneration. The company’s pre-clinical and clinical assets include CAR-T cell receptor an …
  • Visonic Ltd.:企業の戦略的SWOT分析
    Visonic Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆